BPH-1358 mesylate (NSC50460 mesylate), a highly effective inhibitor of both human farnesyl diphosphate synthase (FPPS) and undecaprenyl diphosphate synthase (UPPS), exhibits IC50 values of 1.8 µM and 110 nM, respectively. Additionally, this compound demonstrates potent in vitro activity against S. aureus, with a minimum inhibitory concentration (MIC) approximately 250 ng/mL.
Molecular Weight:
720.82
Formula:
C34H36N6O8S2
Target:
Antibacterial|||Others
T72587
* VAT and and shipping costs not included. Errors and price changes excepted
